Clinical Trial: Study of Efficacy of Levofloxacin 0.5% Ophthalmic Solution Administered Three Times a Day for Bacterial Conjunctivitis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Single- Centre, Randomised Study Of The Clinical And Microbiological Efficacy Of Decreasing The Dosage Of Levofloxacin 0,5% Eye Drops As Compared To Standard Eye Drop Dosage In Patients With Bacteri

Brief Summary: The aim of the study is to evaluate the clinical and microbiological efficacies of three times daily administration of levofloxacin 0,5% eye drops as compared to the more frequent dosing (up to 8 times a day during the first 2 days and up to 4 times a day during the next 3 days) in patients with bacterial conjunctivitis.

Detailed Summary:
Sponsor: Laser Microsurgery Centre, Poland

Current Primary Outcome: The primary efficacy endpoint was the clinical cure. [ Time Frame: 7(+-1) days ]

Original Primary Outcome: Same as current

Current Secondary Outcome: The secondary efficacy end point was the microbiological eradication. [ Time Frame: 7(+-1) days ]

Original Secondary Outcome: Same as current

Information By: Laser Microsurgery Centre, Poland

Dates:
Date Received: November 27, 2007
Date Started: September 2004
Date Completion:
Last Updated: November 28, 2007
Last Verified: November 2007